相关实验视频
Updated: Jul 15, 2025

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
15.8K
黑色素瘤治疗的20年视角
1Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.
Pigment cell & melanoma research
|September 28, 2023
概括
免疫疗法,包括PD-1抗体,已经彻底改变了黑色素瘤治疗. 向的BRAF和MEK疗法也显著改善了黑色素瘤患者的治疗结果,标志着十年的重大进展.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 黑色素瘤治疗历史上依赖于不那么有效的细胞因子免疫疗法.
- 免疫检查点抑制剂,如CTLA-4抗体,显示出有前途.
- 从那时起,PD-1抗体已成为先进黑色素瘤治疗的基石.
研究的目的:
- 审查免疫疗法和向治疗对黑色素瘤治疗的变革性影响.
- 为了突出2010年代黑色素瘤结局的重大进展.
主要方法:
- 审查免疫治疗的进展,包括细胞因子治疗,CTLA-4和PD-1抗体.
- 分析BRAF抑制剂和BRAF/MEK联合治疗的发展和影响.
- 与其他癌症类型相比,研究黑色素瘤治疗结果.
主要成果:
- PD-1抗体显著改善了黑色素瘤治疗的前景,使得超过一半的晚期癌症患者能够接受免疫治疗.
- 在黑色素瘤中,BRAF突变很常见 (近50%),导致有效的向疗法.
- BRAF抑制剂和BRAF/MEK联合治疗在黑色素瘤中取得了显著的成功.
- 黑色素瘤在2010年代经历了前所未有的结果改善.
结论:
- 免疫疗法,特别是PD-1阻断,以及像BRAF/MEK抑制剂这样的向疗法,已经从根本上改变了黑色素瘤的治疗.
- 在过去的十年中,黑色素瘤治疗的进展超过了其他癌症类型的进展.
相关概念视频
Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Tumor Immunotherapy
551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

